The histological diagnosis of metastases to the breast from extramammary malignancies

AHS Lee - Journal of Clinical Pathology, 2007 - jcp.bmj.com
This study aims to review histological and immunohistochemical features that are useful in
the diagnosis of metastases to the breast. Histological features were compared between non …

Targeting the androgen receptor in breast cancer

KM Chia, M O'Brien, M Brown, E Lim - Current oncology reports, 2015 - Springer
The androgen receptor (AR) is expressed in the majority of breast cancer and across the
three main breast cancer subtypes. Historically, the oncogenic role of AR has best been …

Invasive neuroendocrine carcinoma of the breast: a distinctive subtype of aggressive mammary carcinoma

B Wei, T Ding, Y **ng, W Wei, Z Tian, F Tang… - Cancer, 2010 - Wiley Online Library
BACKGROUND: Neuroendocrine carcinoma (NEC) of the breast, a pathologic entity newly
defined in the 2003 World Health Organization classification of tumors, is a rare type of …

Invasive neuroendocrine carcinoma of the breast: a population-based study from the surveillance, epidemiology and end results (SEER) database

J Wang, B Wei, CT Albarracin, J Hu, SC Abraham… - BMC cancer, 2014 - Springer
Background Neuroendocrine carcinoma (NEC) of the breast is a rare type of carcinoma that
has not been well studied or characterized. Of the limited number of studies reported in the …

Androgen receptor expression is a significant prognostic factor in estrogen receptor positive breast cancers

I Castellano, E Allia, V Accortanzo, AM Vandone… - Breast cancer research …, 2010 - Springer
The purpose of this article is to evaluate the prognostic value of androgen receptor (AR)
expression in patients with estrogen receptor (ER)-positive breast cancer, treated with …

[HTML][HTML] Comprehensive clinical and molecular analyses of neuroendocrine carcinomas of the breast

M Lavigne, E Menet, JC Tille, M Lae, L Fuhrmann… - Modern Pathology, 2018 - Elsevier
Neuroendocrine breast carcinomas represent a rare subtype of breast cancer. Their
definition, prevalence, and prognosis remain controversial in the literature. The 2012 WHO …

[HTML][HTML] Quantification of the N-glycosylated secretome by super-SILAC during breast cancer progression and in human blood samples

PJ Boersema, T Geiger, JR Wiśniewski… - Molecular & cellular …, 2013 - Elsevier
Cells secrete a large number of proteins to communicate with their surroundings.
Furthermore, plasma membrane proteins and intracellular proteins can be released into the …

Rare breast lesions: correlation of imaging and histologic features with WHO classification

A Irshad, SJ Ackerman, TL Pope, CK Moses… - Radiographics, 2008 - pubs.rsna.org
Mammographers occasionally are surprised by the diagnosis of a rare lesion at breast
biopsy. The imaging features of some breast lesions are unfamiliar because they are rarely …

Neuroendocrine differentiation in breast cancer: established facts and unresolved problems

L Righi, A Sapino, C Marchio, M Papotti… - Seminars in diagnostic …, 2010 - Elsevier
Neuroendocrine breast carcinoma (NEBC) diagnosis relies on (i) presence of morphologic
neuroendocrine features, and (ii) neuroendocrine markers expressed in more than 50% of …

Tissue microarray analysis of neuroendocrine differentiation and its prognostic significance in breast cancer

N Makretsov, CB Gilks, AJ Coldman, M Hayes… - Human pathology, 2003 - Elsevier
The aim of this study was to detect neuroendocrine differentiation (NE), to determine its
association with major clinicopathological parameters of breast cancer, and to study the …